A Safety and Efficacy Study Comparing Fibrocaps and Tachosil in Hepatic Surgery
- First Posted Date
- 2014-11-05
- Last Posted Date
- 2017-08-16
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 150
- Registration Number
- NCT02284256
- Locations
- 🇩🇪
Krankenhaus Nordwest GmbH, Frankfurt am Main, Germany
🇩🇪Universitaetsklinikum Aachen, RWTH, Aachen, Germany
🇩🇪Universitätsklinikum Heidelberg, Heidelberg, Germany
Topical Raplixa for Surgical Bleeding in Children
- Conditions
- Interventions
- First Posted Date
- 2014-04-17
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 55
- Registration Number
- NCT02117349
- Locations
- 🇺🇸
Carilion Clinic, Roanoke, Virginia, United States
🇺🇸SGM Physician Research Consortium, LLC, Wayne, Pennsylvania, United States
🇺🇸Nemours Children's Specialty Care, Jacksonville, Florida, United States
Safety and Efficacy Study of Acthar in Subjects With ARDS
- Conditions
- Interventions
- First Posted Date
- 2014-04-15
- Last Posted Date
- 2017-09-27
- Lead Sponsor
- Mallinckrodt
- Registration Number
- NCT02113735
Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors
- First Posted Date
- 2014-01-20
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 44
- Registration Number
- NCT02040558
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation
- Conditions
- Interventions
- First Posted Date
- 2013-11-25
- Last Posted Date
- 2019-12-13
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 164
- Registration Number
- NCT01993875
Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac Surgery
- Conditions
- Interventions
- First Posted Date
- 2013-10-10
- Last Posted Date
- 2016-09-09
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 18
- Registration Number
- NCT01959828
- Locations
- 🇯🇵
Osaka University Hospital, Osaka, Japan
🇯🇵National Cerebral and Cardiovascular Center (Pediatric CV Surgery), Osaka, Japan
🇯🇵National Cerebral and Cardiovascular Center (Transplantation), Osaka, Japan
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
- Conditions
- Interventions
- First Posted Date
- 2013-07-24
- Last Posted Date
- 2017-01-06
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 43
- Registration Number
- NCT01906658
- Locations
- 🇺🇸
Questcor Investigational Site, San Antonio, Texas, United States
Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active Disease
- Conditions
- Interventions
- First Posted Date
- 2012-12-20
- Last Posted Date
- 2020-02-27
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 38
- Registration Number
- NCT01753401
- Locations
- 🇺🇸
Mallinckrodt Investigational Site, Houston, Texas, United States
Safety and Efficacy Study of COV155 for Post-operative Bunionectomy Pain
- First Posted Date
- 2012-12-06
- Last Posted Date
- 2016-10-19
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 406
- Registration Number
- NCT01743625
- Locations
- 🇺🇸
Lotus Clinical Research, LLC, Pasadena, California, United States
🇺🇸Anaheim Clinical Trials, Anaheim, California, United States
🇺🇸Endeavor Clinical Trails, PA, San Antonio, Texas, United States
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
- Conditions
- Interventions
- First Posted Date
- 2012-11-07
- Last Posted Date
- 2016-10-19
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 153
- Registration Number
- NCT01722864
- Locations
- 🇺🇸
Probe Clinical Research Corporation - Santa Ana, Santa Ana, California, United States
🇺🇸Martin E. Hale, MD PA (Gold Coast Research LLC), Plantation, Florida, United States
🇺🇸International Clinical Research, LLC, Sanford, Florida, United States